Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Life sciences and health data startup Seer announced recently that it has raised $17.5 million in a series C financing round.

Danaher recently announced that the group will establish an independent company, ENVISTA HOLDINGS CORPORATION (referred to as Envista), and will make an initial public offering in the second half of 2019.

Roche today reported flat half-year revenues for its Diagnostics division. At constant exchange rates, diagnostics revenues were up 2 percent, primarily due to the immunodiagnostics business as well as to overall growth in the second quarter

Freenome announced today that it has closed a $160 million Series B financing round, which it will use to further develop its early cancer detection blood test.

Thermo Fisher Scientific, the world leader in serving science, recently announced that it will be investing more than $50m (£39.8m) in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioproc

A new public-private consortium is collaborating on a project whose chief objective is an FDA-qualified composite biomarker for diagnosing nonalcoholic steatohepatitis (NASH). If all goes as planned, physicians and researchers will for the f

Biodesix isn’t looking to just be another company with lung cancer detection tests. It wants to be the lung cancer detection company. And with its most recent acquisition, the Boulder, CO-just might achieve that goal.

Biological Dynamics is fighting to take its diagnostic platform to the next level. And the San Diego-based company said it recently received a grant from the Bill & Melinda Gates Foundation, to help it in its mission.

ArcherDX is bringing it up a notch through a new collaboration with Ayala Pharmaceuticals, a clinical stage precision oncology company.

At the Massachusetts institute of technology researchers have invented a sensor that can speed up the process of diagnosis of sepsis recently held in Berlin, Germany's engineering conference, medicine and biology, researchers have published